Jie Zang
- Molecular Biology
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Surgery top 10%
- Co-authors
- Yingjie ZhangWenfang XuVictor J. DzauNanette H. BishopricKeith A. WebsterDouglas IngZhaohui ZhuXuewu Liang
- Topics
- Radiopharmaceutical Chemistry and Applications (18 papers)Peptidase Inhibition and Analysis (18 papers)Sarcoma Diagnosis and Treatment (15 papers)
- Partner nations
- ChinaUnited StatesDenmark
In The Last Decade
Jie Zang
90 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 99
- Molecular Biology 655
- Oncology 593
- Pulmonary and Respiratory Medicine 477
- Radiology, Nuclear Medicine and Imaging 404
- Surgery 330
Countries citing papers authored by Jie Zang
This map shows the geographic impact of Jie Zang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Zang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Zang more than expected).
Fields of papers citing papers by Jie Zang
This network shows the impact of papers produced by Jie Zang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Zang. The network helps show where Jie Zang may publish in the future.
Co-authorship network of co-authors of Jie Zang
This figure shows the co-authorship network connecting the top 25 collaborators of Jie Zang. A scholar is included among the top collaborators of Jie Zang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Zang. Jie Zang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 10 | |
| 8 | 11 | |
| 9 | 10 | |
| 10 | 15 | |
| 11 | 5 | |
| 12 | 24 | |
| 13 | 10 | |
| 14 | 11 | |
| 15 | 8 | |
| 16 | 96 | |
| 17 | 改善されたHDAC阻害活性及びin vitro抗腫瘍作用を有するN‐ヒドロキシシンナムアミドに基づくHDAC阻害剤の開発 | 1 |
| 18 | 47 | |
| 19 | 21 | |
| 20 | 32 |
About Jie Zang
Jie Zang is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 95 papers that have together received 2.0k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (18 papers), Peptidase Inhibition and Analysis (18 papers) and Sarcoma Diagnosis and Treatment (15 papers). The work is most often cited by research in Oncology (593 citations), Radiology, Nuclear Medicine and Imaging (404 citations) and Pulmonary and Respiratory Medicine (477 citations). Jie Zang has collaborated with scholars based in China, United States and Denmark. Frequent co-authors include Yingjie Zhang, Wenfang Xu, Victor J. Dzau, Nanette H. Bishopric, Keith A. Webster, Douglas Ing, Zhaohui Zhu, Xuewu Liang, Qingxing Liu and Xiaoyang Li. Their work appears in journals such as Angewandte Chemie International Edition, PLoS ONE and Circulation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.